Civeo Corp current report, 02 February 2017

Civeo Corp. 8-K Summary

Business Context and Reporting Period

Civeo Corporation (Civeo) filed this Current Report on Form 8-K on February 2, 2017, to disclose a significant capital raising event. The Company is incorporated in British Columbia, Canada, with principal executive offices in Houston, Texas.

Key Financial Metrics and Transaction Details

  • Offering Size: 20,000,000 common shares sold at $3.00 per share.
  • Over-Allotment: Underwriters exercised their option in full to purchase an additional 3,000,000 shares at the same price.
  • Total Shares Issued: 23,000,000 common shares.
  • Expected Net Proceeds: Approximately $64.9 million (net of underwriting discounts and estimated offering expenses).
  • Use of Proceeds: Repayment of amounts outstanding under revolving credit facilities and general corporate purposes.
  • Closing Date: Expected on February 7, 2017.

Note: This filing does not provide specific revenue, profit, cash flow, margin, or existing debt figures for the Company.

Material Changes

The primary material change is the execution of an underwriting agreement with RBC Capital Markets, LLC, resulting in a significant increase in outstanding common shares and an influx of capital intended to reduce leverage on revolving credit facilities.

Outlook, Risks, and Contingencies

The transaction is subject to customary closing conditions. The Company has agreed to indemnify the underwriters against certain liabilities under the Securities Act. The filing references a prospectus supplement for further details on risks and terms.

Investor Verification Checklist

  • Verify the final closing date and actual net proceeds received on or after February 7, 2017.
  • Confirm the specific amount of revolving credit facility debt repaid with the proceeds.
  • Review the full Underwriting Agreement (Exhibit 1.1) for specific indemnification clauses and lock-up periods.
  • Check subsequent filings for the impact of the 23,000,000 new shares on earnings per share (EPS) dilution.